Allosteric regulation of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines

  title={Allosteric regulation of $\alpha$-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines},
  author={Sean D. Donevan and Michael A. Rogawski},

Figures and Tables from this paper

Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors
Results indicate that S 47445 is a potent and selective AMPA-PAM presenting procognitive and potential neuroprotective properties and does not demonstrate neurotoxic effect against glutamate-mediated excitotoxicity in vitro.
AMPA receptor ligand-binding domain: Site-directed mutagenesis study of ligand-receptor interactions
Characterization of ligand-binding domains of GluR-B and GLUR-D glutamate receptor subunits expressed as periplasmic proteins in Eschericia coli and implications for redox modulation of glutamate receptors are presented.
Role of desensitization of AMPA receptors on the neuronal viability and on the [Ca2+]i changes in cultured rat hippocampal neurons
Overall, the results clearly show that there exist different populations of hippocampal neurons with different sensitivities to kainate, AMPA, CTZ and LY 303070, and the effects of CTZ on both [Ca2+]i alterations and neurotoxicity are not fully correlated.


Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
Cyclothiazide seems to interact at a site on the AMPA receptor complex which differs from either the glutamate recognition site or the 2,3-benzodiazepine allosteric site.
Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
The study suggests that GYKI 53655, at a concentration of approximately 10 microM, should produce > 90% block of AMPA-preferring receptors but < 5% inhibition of kainate-preferredring receptors, making it an ideal compound for functional studies of the role ofkainate and AMPA receptors in synaptic transmission.
Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
The increased affinity of the 3-N-substituted analogs relates to their increased binding and decreased unbinding rates, which are inversely correlated with increasing blocking potency.
Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
The data suggest that the effect of cyclothiazide on the affinity of GYKI-52466 for its binding site is allosteric and that the positive modulatory effect ofcyclothiazides and the negative modulatory effects of GyKI-52366 result from binding to separate sites on recombinant subunits.
Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
The results suggest that the flip/flop module could directly contribute to the binding site for cyclothiazide, raising the possibility that this site is located in an extracellular receptor domain.
Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
Analysis of the results with a kinetic model of the AMPA receptor suggests that cyclothiazide does not block receptor desensitization by making the desensitized state inaccessible but rather by stabilizing the active state, i.e., by increasing the affinity of the latter to a point where it becomes energetically more favorable than the desENSitized state.
Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists
The results indicate that cyclothiazide allosterically influences two important antagonist sites on AMPA receptors, and AMPA/kainate receptor subunit composition influences the affinity of GYKI for the receptor.
Interactions of 2,3‐benzodiazepines and cydothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices
1 The 2,3‐benzodiazepines GYKI 52466, GYKI 53405 and GYKI 53655 antagonized AMPA‐induced currents in cultured superior colliculus neurones in a non use‐dependent manner (steady state IC50S: GYKI